Sumitomo Pharma Co.ltd — Dainippon Sumitomo Pharma — Earnings Presentation (November 2005)

9 slides from Sumitomo Pharma Co.ltd's earnings presentation, Nov 9, 2005

Slide 1: 18 3
18 3 17 11 9 0
Slide 2: % 5/16 9/29 105.6 (5.2) (10.6) 213.8 (5.4) 43 39 77 (10.0) 85 195.5
18 3 % 5/16 9/29 802 820 840 847 105.6 (5.2) 42 40 81 (10.6) 90 213.8 (5.4) 43 39 77 (10.0) 85 195.5 (3.3) 26 7 34 (4.7) 40 151.6 1
Slide 3: % 5/16 11/8 1,739 2,440 2,450 140.9 (6.0) (9.1) 3 214.5 (6.4) 112 195
18 3 % 5/16 11/8 1,739 2,440 2,450 140.9 (6.0) 104 205 (9.1) 223 214.5 (6.4) 112 195 (8.6) 210 187.7 (4.0) 69 101 (4.5) 110 158.9 2
Slide 4: CNS
f, DAINIPPON é Py SUMITOMO 4 PHARMA > 2006 3 MR
Slide 5: ¾ EBM ¾ FD FD
fA DAINIPPON = <> sumitomo 4 PHARMA FD JMMS
Slide 6: f f f
f f f 5
Slide 7: SM-13496 Merck & Co., Inc. AS-3201
18 3 SM-13496 Merck & Co., Inc. ¾ AS-3201 ¾ ¾ 10 11 2006 1 ¾ OD ¾ 7 ¾ 12 6
Slide 8: AINIPPON,
AINIPPON, Sfx ranurron Jv Y PHARMA = 07 3 O7 4 05 06 10 4
Slide 9: «<fA_ vainirron
«<fA_ vainirron <9 SUMITOMO J Y PHARMA